Diastolic Dysfunction in Liver Cirrhosis: Prognostic Predictor in Liver Transplantation?

F Carvalheiro1, C Rodrigues2, T Adrego3

  • 1Department of Anesthesia, Centro Hospitalar do Algarve, Portimão, Portugal.

Transplantation Proceedings
|February 27, 2016
PubMed

Insights

Diastolic dysfunction (DD) is common in liver cirrhosis patients before liver transplantation (LT). This cardiac condition, along with a prolonged QTc interval, can increase mortality risk after LT.

Area of Science:

  • Cardiology
  • Hepatology
  • Transplantation Medicine

Background:

  • Liver cirrhosis can lead to cirrhotic cardiomyopathy (CC).
  • CC is marked by impaired contractile response to stress, diastolic dysfunction (DD), and electrical abnormalities.
  • These cardiac issues can negatively impact patient prognosis.

Purpose of the Study:

  • To analyze the prevalence of diastolic dysfunction (DD) and prolonged QTc interval in patients with liver cirrhosis awaiting liver transplantation (LT).
  • To investigate the correlation between these cardiac abnormalities and post-LT outcomes, including mortality.

Main Methods:

  • Retrospective analysis of 106 patients undergoing LT between January 2012 and June 2015.
  • Evaluation of demographic data, cirrhosis etiology, Child-Pugh and MELD scores, preoperative QTc interval, and cardiac function (systolic and diastolic).
  • Statistical comparison of DD and QTc prolongation with MELD/Child-Pugh scores and post-LT outcomes using chi-square, Fisher, and Mann-Whitney U tests.

Main Results:

  • The study included 106 patients (80.2% male, average age 54.83 years).
  • Prevalence of prolonged QTc was 19% and DD was 35.8%.
  • No significant association was found between QTc prolongation or DD and MELD or Child-Pugh scores.

Conclusions:

  • A significant incidence of diastolic dysfunction (DD) was observed in patients pre-LT, indicating a predisposition to adverse cardiac events.
  • The presence of DD is associated with increased mortality following liver transplantation in patients with hepatic cirrhosis.
Abstract